Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion

Groupe Francais De Pneumo-Cancerologie · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
nanon-small-cell-lung-cancer
non-small cell lung cancer, egfr exon 20 insertion mutation, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 807165
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.